Average Co-Inventor Count = 10.22
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Compugen Ltd. Corporation (18 from 61 patents)
2. Protalix Ltd. (1 from 25 patents)
3. Gavish-Galilee Bio Applications Ltd. (1 from 14 patents)
4. Immpact-Bio Ltd. (1 from 1 patent)
19 patents:
1. 11660315 - Universal platform for preparing an inhibitory chimeric antigen receptor (iCAR)
2. 8987191 - Bioactive peptides and methods of using same
3. 8828940 - Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands
4. 8492329 - Bioactive peptides and methods of using same
5. 8349801 - Peptide ligands for G-protein coupled receptors
6. 7939634 - Polynucleotides encoding polypeptides and methods using same
7. 7906635 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
8. 7884180 - Peptides which bind to G protein-coupled receptors
9. 7842459 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
10. 7745391 - Human thrombospondin polypeptide
11. 7714100 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
12. 7678769 - Hepatocyte growth factor receptor splice variants and methods of using same
13. 7667001 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
14. 7655781 - Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
15. 7569662 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer